{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:45:03Z","timestamp":1773949503075,"version":"3.50.1"},"reference-count":40,"publisher":"American Association for Cancer Research (AACR)","issue":"11","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Aberrant AKT (protein kinase B) signaling is common in many cancers, including glioblastoma. Current models suggest that AKT acts directly, or indirectly via the TSC complex, to activate the mammalian target of rapamycin (mTOR) as the main downstream mediator of AKT signaling. mTOR activation results in subsequent activation of S6K and STAT3, as well as suppression (i.e., phosphorylation) of 4E-BP1, leading to cell cycle progression and inhibition of apoptosis. Most studies of this pathway have used in vitro systems or tumor lysate\u2013based approaches. We aimed to delineate these pathways in a primarily in situ manner using immunohistochemistry in a panel of 29 glioblastomas, emphasizing the histologic distribution of molecular changes. Within individual tumors, increased expression levels of p-TSC2, p-mTOR, p-4E-BP1, p-S6K, p-S6, and p-STAT3 were found in regions defined by elevated AKT activation. However, only TSC2, S6K, and S6 activation levels correlated significantly with AKT activation and clustered together in multidimensional scaling analyses. Ki-67 proliferation indices were significantly elevated in p-AKT-overexpressing regions, whereas expression of the apoptosis marker cleaved caspase 3 was generally low and not significantly different between the regions. These findings provide the first in vivo evidence for a close correlation between AKT and TSC2 phosphorylation levels in glioblastoma. Moreover, they suggest that downstream p-AKT effects are primarily mediated by S6 kinase signaling, thus enhancing proliferation rather than inhibiting apoptosis. (Cancer Res 2006; 66(11): 5618-23)<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-0364","type":"journal-article","created":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T17:15:12Z","timestamp":1149182112000},"page":"5618-5623","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":102,"title":["AKT Activation in Human Glioblastomas Enhances Proliferation via TSC2 and S6 Kinase Signaling"],"prefix":"10.1158","volume":"66","author":[{"given":"Markus J.","family":"Riemenschneider","sequence":"first","affiliation":[{"name":"1Department of Pathology, Molecular Neuro-Oncology Laboratory, Molecular Pathology Unit and Cancer Center, Massachusetts General Hospital and Harvard Medical School;"},{"name":"3Department of Neuropathology, Heinrich-Heine-University, Dusseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca A.","family":"Betensky","sequence":"additional","affiliation":[{"name":"2Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia M.","family":"Pasedag","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Molecular Neuro-Oncology Laboratory, Molecular Pathology Unit and Cancer Center, Massachusetts General Hospital and Harvard Medical School;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David N.","family":"Louis","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Molecular Neuro-Oncology Laboratory, Molecular Pathology Unit and Cancer Center, Massachusetts General Hospital and Harvard Medical School;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2006,6,1]]},"reference":[{"key":"2022061621043639300_B1","unstructured":"Kleihues P, Cavenee WK, editors. International Agency for Research on Cancer. Pathology and genetics of tumours of the nervous system. Lyon: IARC Press; 2000."},{"key":"2022061621043639300_B2","doi-asserted-by":"crossref","unstructured":"Reifenberger G, Collins VP. Pathology and molecular genetics of astrocytic gliomas. J Mol Med\u20082004; 82: 656\u201370.","DOI":"10.1007\/s00109-004-0564-x"},{"key":"2022061621043639300_B3","doi-asserted-by":"crossref","unstructured":"Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE, Fuller GN. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet\u20082000; 25: 55\u20137.","DOI":"10.1038\/75596"},{"key":"2022061621043639300_B4","unstructured":"Sonoda Y, Ozawa T, Aldape KD, et al. Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. Cancer Res\u20082001; 61: 6674\u20138."},{"key":"2022061621043639300_B5","doi-asserted-by":"crossref","unstructured":"Bjornsti MA, Houghton PJ. The TOR pathway: a target for cancer therapy. Nat Rev Cancer\u20082004; 4: 335\u201348.","DOI":"10.1038\/nrc1362"},{"key":"2022061621043639300_B6","doi-asserted-by":"crossref","unstructured":"Jacinto E, Hall MN. Tor signalling in bugs, brain and brawn. Nat Rev Mol Cell Biol\u20082003; 4: 117\u201326.","DOI":"10.1038\/nrm1018"},{"key":"2022061621043639300_B7","doi-asserted-by":"crossref","unstructured":"Abraham RT. Identification of TOR signaling complexes: more TORC for the cell growth engine. Cell\u20082002; 111: 9\u201312.","DOI":"10.1016\/S0092-8674(02)01009-7"},{"key":"2022061621043639300_B8","doi-asserted-by":"crossref","unstructured":"Inoki K, Li Y, Zhu T, Wu J, Guan KL. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol\u20082002; 4: 648\u201357.","DOI":"10.1038\/ncb839"},{"key":"2022061621043639300_B9","doi-asserted-by":"crossref","unstructured":"Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway. Mol Cell\u20082002; 10: 151\u201362.","DOI":"10.1016\/S1097-2765(02)00568-3"},{"key":"2022061621043639300_B10","doi-asserted-by":"crossref","unstructured":"Han S, Santos TM, Puga A, et al. Phosphorylation of tuberin as a novel mechanism for somatic inactivation of the tuberous sclerosis complex proteins in brain lesions. Cancer Res\u20082004; 64: 812\u20136.","DOI":"10.1158\/0008-5472.CAN-03-3277"},{"key":"2022061621043639300_B11","doi-asserted-by":"crossref","unstructured":"Zhang Y, Gao X, Saucedo LJ, et al. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat Cell Biol\u20082003; 5: 578\u201381.","DOI":"10.1038\/ncb999"},{"key":"2022061621043639300_B12","doi-asserted-by":"crossref","unstructured":"Volarevic S, Thomas G. Role of S6 phosphorylation and S6 kinase in cell growth. Prog Nucleic Acid Res Mol Biol\u20082001; 65: 101\u201327.","DOI":"10.1016\/S0079-6603(00)65003-1"},{"key":"2022061621043639300_B13","doi-asserted-by":"crossref","unstructured":"Gingras AC, Raught B, Sonenberg N. Regulation of translation initiation by FRAP\/mTOR. Genes Dev\u20082001; 15: 807\u201326.","DOI":"10.1101\/gad.887201"},{"key":"2022061621043639300_B14","doi-asserted-by":"crossref","unstructured":"Hara K, Yonezawa K, Kozlowski MT, et al. Regulation of eIF-4E BP1 phosphorylation by mTOR. J Biol Chem\u20081997; 272: 26457\u201363.","DOI":"10.1074\/jbc.272.42.26457"},{"key":"2022061621043639300_B15","doi-asserted-by":"crossref","unstructured":"Yokogami K, Wakisaka S, Avruch J, Reeves SA. Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr Biol\u20082000; 10: 47\u201350.","DOI":"10.1016\/S0960-9822(99)00268-7"},{"key":"2022061621043639300_B16","doi-asserted-by":"crossref","unstructured":"Rajan P, Panchision DM, Newell LF, McKay RD. BMPs signal alternately through a SMAD or FRAP-STAT pathway to regulate fate choice in CNS stem cells. J Cell Biol\u20082003; 161: 911\u201321.","DOI":"10.1083\/jcb.200211021"},{"key":"2022061621043639300_B17","doi-asserted-by":"crossref","unstructured":"Wen Z, Zhong Z, Darnell JE, Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell\u20081995; 82: 241\u201350.","DOI":"10.1016\/0092-8674(95)90311-9"},{"key":"2022061621043639300_B18","doi-asserted-by":"crossref","unstructured":"Jaeschke A, Hartkamp J, Saitoh M, et al. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent. J Cell Biol\u20082002; 159: 217\u201324.","DOI":"10.1083\/jcb.jcb.200206108"},{"key":"2022061621043639300_B19","doi-asserted-by":"crossref","unstructured":"Holz MK, Blenis J. Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase. J Biol Chem\u20082005; 280: 26089\u201393.","DOI":"10.1074\/jbc.M504045200"},{"key":"2022061621043639300_B20","doi-asserted-by":"crossref","unstructured":"Galanis E, Buckner JC, Maurer MJ, et al. Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study. J Clin Oncol\u20082005; 23: 5294\u2013304.","DOI":"10.1200\/JCO.2005.23.622"},{"key":"2022061621043639300_B21","doi-asserted-by":"crossref","unstructured":"Riemenschneider MJ, Mueller W, Betensky RA, Mohapatra G, Louis DN. In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation. Am J Pathol\u20082005; 167: 1379\u201387.","DOI":"10.1016\/S0002-9440(10)61225-4"},{"key":"2022061621043639300_B22","doi-asserted-by":"crossref","unstructured":"Dai H, Holm R, Kristensen GB, et al. Fibroblast growth factor receptor 3 (FGFR3)\u2014analyses of the S249C mutation and protein expression in primary cervical carcinomas. Anal Cell Pathol\u20082001; 23: 45\u20139.","DOI":"10.1155\/2001\/521873"},{"key":"2022061621043639300_B23","unstructured":"Krajewska M, Krajewski S, Epstein JI, et al. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Am J Pathol\u20081996; 148: 1567\u201376."},{"key":"2022061621043639300_B24","doi-asserted-by":"crossref","unstructured":"Hastie T, Tibshirani R, Friedman J, editors. Elements of statistical learning. New York: Springer; 2001.","DOI":"10.1007\/978-0-387-21606-5"},{"key":"2022061621043639300_B25","doi-asserted-by":"crossref","unstructured":"Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev\u20082004; 18: 1926\u201345.","DOI":"10.1101\/gad.1212704"},{"key":"2022061621043639300_B26","doi-asserted-by":"crossref","unstructured":"Chen Y, Zheng Y, Foster DA. Phospholipase D confers rapamycin resistance in human breast cancer cells. Oncogene\u20082003; 22: 3937\u201342.","DOI":"10.1038\/sj.onc.1206565"},{"key":"2022061621043639300_B27","doi-asserted-by":"crossref","unstructured":"Dennis PB, Jaeschke A, Saitoh M, et al. Mammalian TOR: a homeostatic ATP sensor. Science\u20082001; 294: 1102\u20135.","DOI":"10.1126\/science.1063518"},{"key":"2022061621043639300_B28","doi-asserted-by":"crossref","unstructured":"Wang L, Fraley CD, Faridi J, Kornberg A, Roth RA. Inorganic polyphosphate stimulates mammalian TOR, a kinase involved in the proliferation of mammary cancer cells. Proc Natl Acad Sci U S A\u20082003; 100: 11249\u201354.","DOI":"10.1073\/pnas.1534805100"},{"key":"2022061621043639300_B29","doi-asserted-by":"crossref","unstructured":"Arsham AM, Howell JJ, Simon MC. A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J Biol Chem\u20082003; 278: 29655\u201360.","DOI":"10.1074\/jbc.M212770200"},{"key":"2022061621043639300_B30","doi-asserted-by":"crossref","unstructured":"Roux PP, Ballif BA, Anjum R, Gygi SP, Blenis J. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc Natl Acad Sci U S A\u20082004; 101: 13489\u201394.","DOI":"10.1073\/pnas.0405659101"},{"key":"2022061621043639300_B31","doi-asserted-by":"crossref","unstructured":"Shaw RJ, Bardeesy N, Manning BD, et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell\u20082004; 6: 91\u20139.","DOI":"10.1016\/j.ccr.2004.06.007"},{"key":"2022061621043639300_B32","doi-asserted-by":"crossref","unstructured":"Brugarolas J, Lei K, Hurley RL, et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex. Genes Dev\u20082004; 18: 2893\u2013904.","DOI":"10.1101\/gad.1256804"},{"key":"2022061621043639300_B33","doi-asserted-by":"crossref","unstructured":"Loewith R, Jacinto E, Wullschleger S, et al. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol Cell\u20082002; 10: 457\u201368.","DOI":"10.1016\/S1097-2765(02)00636-6"},{"key":"2022061621043639300_B34","doi-asserted-by":"crossref","unstructured":"Martin DE, Hall MN. The expanding TOR signaling network. Curr Opin Cell Biol\u20082005; 17: 158\u201366.","DOI":"10.1016\/j.ceb.2005.02.008"},{"key":"2022061621043639300_B35","unstructured":"Choe G, Horvath S, Cloughesy TF, et al. Analysis of the phosphatidylinositol 3\u2032-kinase signaling pathway in glioblastoma patients in vivo. Cancer Res\u20082003; 63: 2742\u20136."},{"key":"2022061621043639300_B36","doi-asserted-by":"crossref","unstructured":"Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev\u20081999; 13: 2905\u201327.","DOI":"10.1101\/gad.13.22.2905"},{"key":"2022061621043639300_B37","doi-asserted-by":"crossref","unstructured":"Osaki M, Oshimura M, Ito H. PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis\u20082004; 9: 667\u201376.","DOI":"10.1023\/B:APPT.0000045801.15585.dd"},{"key":"2022061621043639300_B38","doi-asserted-by":"crossref","unstructured":"Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol\u20082000; 182: 311\u201322.","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9"},{"key":"2022061621043639300_B39","doi-asserted-by":"crossref","unstructured":"Marshman E, Ottewell PD, Potten CS, Watson AJ. Caspase activation during spontaneous and radiation-induced apoptosis in the murine intestine. J Pathol\u20082001; 195: 285\u201392.","DOI":"10.1002\/path.967"},{"key":"2022061621043639300_B40","doi-asserted-by":"crossref","unstructured":"Duan WR, Garner DS, Williams SD, et al. Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J Pathol\u20082003; 199: 221\u20138.","DOI":"10.1002\/path.1289"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/11\/5618\/2548656\/5618.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/11\/5618\/2548656\/5618.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T18:25:07Z","timestamp":1655403907000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/11\/5618\/525610\/AKT-Activation-in-Human-Glioblastomas-Enhances"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,1]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2006,6,1]]},"published-print":{"date-parts":[[2006,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-0364","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718384254.793495051","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,1]]}}}